Earnest Partners LLC decreased its stake in Plexus Corp. (NASDAQ:PLXS - Free Report) by 4.7% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 711,566 shares of the technology company's stock after selling 35,208 shares during the quarter. Earnest Partners LLC owned about 2.64% of Plexus worth $102,956,000 at the end of the most recent reporting period.
Several other hedge funds and other institutional investors also recently bought and sold shares of the stock. AQR Capital Management LLC grew its stake in shares of Plexus by 103.1% during the first quarter. AQR Capital Management LLC now owns 8,384 shares of the technology company's stock valued at $1,074,000 after buying an additional 4,255 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Plexus by 4.6% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 15,971 shares of the technology company's stock valued at $2,046,000 after acquiring an additional 705 shares during the period. United Services Automobile Association bought a new position in Plexus in the 1st quarter valued at $218,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC grew its position in Plexus by 12.9% in the 1st quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 79,584 shares of the technology company's stock valued at $10,197,000 after acquiring an additional 9,078 shares during the last quarter. Finally, Bank of Montreal Can increased its stake in Plexus by 4.0% in the second quarter. Bank of Montreal Can now owns 4,488 shares of the technology company's stock worth $607,000 after purchasing an additional 172 shares during the period. Hedge funds and other institutional investors own 94.45% of the company's stock.
Plexus Stock Up 0.5%
NASDAQ:PLXS opened at $190.74 on Friday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.59 and a quick ratio of 0.75. Plexus Corp. has a 1-year low of $103.43 and a 1-year high of $211.84. The company has a 50-day moving average of $188.27 and a 200 day moving average of $160.05. The firm has a market cap of $5.11 billion, a PE ratio of 29.66 and a beta of 0.81.
Plexus (NASDAQ:PLXS - Get Free Report) last posted its earnings results on Wednesday, January 28th. The technology company reported $1.78 EPS for the quarter, beating analysts' consensus estimates of $1.77 by $0.01. Plexus had a net margin of 4.28% and a return on equity of 12.39%. The business had revenue of $1.07 billion for the quarter, compared to the consensus estimate of $1.07 billion. During the same quarter last year, the firm posted $1.73 EPS. The company's revenue for the quarter was up 9.6% on a year-over-year basis. Plexus has set its Q2 2026 guidance at 1.800-1.950 EPS. As a group, research analysts anticipate that Plexus Corp. will post 5.9 EPS for the current fiscal year.
Insider Buying and Selling at Plexus
In other news, CEO Todd P. Kelsey sold 5,231 shares of the business's stock in a transaction on Wednesday, February 18th. The stock was sold at an average price of $195.78, for a total value of $1,024,125.18. Following the completion of the transaction, the chief executive officer directly owned 83,291 shares of the company's stock, valued at approximately $16,306,711.98. The trade was a 5.91% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, COO Oliver K. Mihm sold 9,541 shares of Plexus stock in a transaction dated Wednesday, February 18th. The shares were sold at an average price of $201.40, for a total value of $1,921,557.40. Following the completion of the transaction, the chief operating officer owned 12,809 shares in the company, valued at $2,579,732.60. This trade represents a 42.69% decrease in their position. The disclosure for this sale is available in the SEC filing. In the last three months, insiders have sold 47,995 shares of company stock worth $9,718,476. 1.78% of the stock is currently owned by company insiders.
Analyst Upgrades and Downgrades
A number of analysts have recently issued reports on the stock. Weiss Ratings raised shares of Plexus from a "hold (c+)" rating to a "buy (b-)" rating in a research note on Friday, March 6th. Zacks Research upgraded shares of Plexus from a "hold" rating to a "strong-buy" rating in a report on Friday, February 6th. Williams Trading set a $195.00 price objective on shares of Plexus in a research report on Wednesday, January 28th. Benchmark raised their target price on shares of Plexus from $165.00 to $195.00 and gave the stock a "buy" rating in a research report on Wednesday, January 28th. Finally, Stifel Nicolaus lifted their price target on shares of Plexus from $150.00 to $200.00 and gave the company a "hold" rating in a research note on Friday, January 30th. One analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $189.20.
Read Our Latest Stock Analysis on Plexus
About Plexus
(
Free Report)
Plexus Corp. NASDAQ: PLXS is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.
Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.
Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Plexus, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Plexus wasn't on the list.
While Plexus currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2026 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report